Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Publications
All →
28 August 2025
Good practices for blood establishments
Blood transfusion is a vital component of modern health care and can be life-saving in many clinical situations. However, it is not without risks, including...
14 May 2025
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety:...
WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual...
23 April 2025
Guidance on implementing patient blood management to improve global blood health status
Incorporating expertise from peers working in countries where health care faces extreme resource constraints, attention is paid to how PBM processes...
16 April 2025
WHO Drug Information - Volume 39, No. 1
The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...
Journal articles
The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
Front Pharmacol. 2020 Sep 11;11:578000
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Clinical Microbiology and Infection 30 (2024) S1eS51
Identifying and costing common gaps in Central and West Africa pharmaceutical regulation
Front. Med., 05 April 2024 Sec. Regulatory Science
